Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CBM

Cambrex (CBM) Stock Price, News & Analysis

Cambrex logo

About Cambrex Stock (NYSE:CBM)

Advanced Chart

Key Stats

Today's Range
$59.99
$59.99
50-Day Range
$59.99
$59.99
52-Week Range
$33.80
$60.29
Volume
N/A
Average Volume
218,726 shs
Market Capitalization
$2.02 billion
P/E Ratio
21.66
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambrex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBM Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
China CBM Group Co Ltd 08270
See More Headlines

CBM Stock Analysis - Frequently Asked Questions

Cambrex Co. (NYSE:CBM) issued its quarterly earnings data on Thursday, August, 2nd. The biotechnology company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.05. The company's revenue was up 13.0% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cambrex investors own include Bristol Myers Squibb (BMY), Illumina (ILMN), AbbVie (ABBV), Meta Platforms (META), CVS Health (CVS), Gilead Sciences (GILD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/02/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:CBM
CIK
820081
Fax
N/A
Employees
1,732
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$2.77
Trailing P/E Ratio
21.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$92.41 million
Net Margins
5.96%
Pretax Margin
N/A
Return on Equity
5.38%
Return on Assets
2.50%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
2.37
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$532.09 million
Price / Sales
3.80
Cash Flow
$3.91 per share
Price / Cash Flow
15.36
Book Value
$19.48 per share
Price / Book
3.08

Miscellaneous

Outstanding Shares
33,720,000
Free Float
N/A
Market Cap
$2.02 billion
Optionable
Optionable
Beta
2.14
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:CBM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners